Lifecore Biomedical, Inc. LFCR Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s change in accrued liabilities?
- Lifecore Biomedical, Inc. (LFCR) reported change in accrued liabilities of -$3.65M in Q1 2026.
- How has Lifecore Biomedical, Inc.'s change in accrued liabilities changed year-over-year?
- Lifecore Biomedical, Inc.'s change in accrued liabilities decreased by 4.4% year-over-year, from -$3.5M to -$3.65M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.